Here's the stealthy reason stocks are at record highs

S&P 500 2026 and 2027 earnings estimates are now 4% above January levels, with positive revisions concentrated in energy and information technology. Micron and Exxon Mobil have accounted for more than 60% of the revision to 2026 S&P 500 EPS estimates, while the index has rallied 12% from its March 30 low and moved above 7,000 for the first time. The article argues that improving earnings expectations, solid bank results, and resilient consumer spending are providing the fundamental backing for the market's record highs despite geopolitical uncertainty.

Analysis

The market is effectively treating earnings revisions as a more durable signal than macro headlines, which is usually the right call once estimate breadth turns up. The important second-order effect is that this revision cycle is extremely concentrated: when a narrow set of mega-caps carries the index, breadth can look healthy on the surface while the median stock still sees flat fundamentals. That setup tends to support the index longer than it supports active managers, because passive flows keep rewarding the same few names even as cyclicals and smaller caps lag in earnings elasticity.

The bigger takeaway is that geopolitics has become a volatility source, not the primary earnings driver. If the conflict premium fades, the market is not just getting relief on risk sentiment; it is also likely to get a broader revisions tailwind via lower input-cost uncertainty, easing capex hesitation, and improved forward guidance from industrial and consumer companies. That creates a path for leadership rotation away from the current narrow earnings beneficiaries into banks, staples, and select industrials over the next 1-2 quarters.

The contrarian risk is that the market is extrapolating a revision inflection from a handful of names rather than a true demand-led reacceleration. If revisions for the dominant contributors stall, index-level earnings momentum can flatten quickly even while the headline index stays elevated on multiple expansion. In that case, the most vulnerable positions are crowded quality-growth exposures and high-duration megacap tech, where valuations assume the revision cycle broadens but operating leverage remains concentrated.

Key Decisions for Investors

• Add to GS/JPM/BAC on pullbacks over the next 2-6 weeks; the best risk/reward is in lenders and markets businesses that benefit if revisions broaden and credit stays benign. Use a tight stop if management commentary turns to consumer delinquency or deposit pressure.
• Own XOM selectively as a geopolitical hedge, but reduce upside expectations: the stock is more useful as a volatility buffer than a pure beta long. Pair part of the position against a basket of reflation-sensitive industrials if crude risk premium collapses.
• Initiate a relative-value long XLF / short equal-weight S&P trade for 1-3 months; the thesis is that earnings breadth improves faster inside financials than at the index level, with lower multiple risk than straight index longs.
• Fade crowded megacap leadership via short-dated call spreads on the index or on the largest revision beneficiaries if estimates stop moving higher. This is a tactical hedge against a revision stall while preserving upside if breadth unexpectedly improves.
• Own PEP as a defensive consumer-demand barometer over the next earnings cycle; if management can hold guidance while input costs stabilize, staples can re-rate as a 'no recession' confirmation trade, but trim if elasticity worsens.